Clinical Trial: Azilect + Antidepressant Chart Review

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Investigation of the Occurrence of Serotonin Toxicity in Parkinson's Disease (PD) Patients Treated Concomitantly With Rasagiline and Antidepressants, Using Retrospective Chart Review

Brief Summary: To identify the occurrence of serotonin toxicity in Parkinson's Disease (PD) patients receiving antidepressant therapy and rasagiline, compared to those receiving rasagiline without antidepressant medications and compared to PD patients receiving antidepressants, but not rasagiline.

Detailed Summary:
Sponsor: Teva Pharmaceutical Industries

Current Primary Outcome: The frequency of serotonin toxicity, as determined by the Adjudication Committee will be calculated for each Group. The primary comparison will be Group R+AD vs. Group R and vs. Group AD [ Time Frame: 9 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Teva Pharmaceutical Industries

Dates:
Date Received: August 6, 2009
Date Started: July 2009
Date Completion:
Last Updated: February 2, 2017
Last Verified: February 2017